დასაწყისი · კატალოგი · პროფილი · ცხრილი
დანამატები BODY HANDBOOK
დანამატები · §536
Omega-3 (EPA and DHA)
Two huge trials at 4 grams a day reached opposite answers on whether fish oil prevents heart attacks, and that disagreement still isn't settled. The honest read across the rest of the evidence is narrower: omega-3 helps people who barely eat oily fish, people with high triglycerides on a statin, and as an add-on for depression that hasn't fully responded to its antidepressant — and probably doesn't help everyone else. EPA does most of the cardiovascular and mood work; DHA gets built into brain and retina. At high doses, the same supplements that lower triglycerides nudge up the risk of atrial fibrillation, so "more is better" is wrong.
გააკეთე · ყოველდღე მტკიცებულება ზომიერი თავი დანამატები

If your triglycerides are high, prescription fish oil is one of the most reliable lab moves in nutrition — 20-30% lower within a couple of months. If you eat almost no oily fish, supplementing closes a real gap that shows up as fewer heart attacks years later, especially in the people who started furthest behind. For depression that's stuck on an antidepressant, EPA-heavy fish oil is a defensible add-on. For everyone else — a salmon-twice-a-week reader — the rest of the bottle mostly does nothing. Strong evidence, narrow indication, a real catch at high doses.

Omega-3s do their work after they've been built into the membranes of your cells. EPA and DHA displace omega-6 fats sitting in those membranes, which changes what signals your cells release when something irritates them: less of the inflammatory family that drives joint pain and arterial plaque, more of a class of signals called specialized pro-resolving mediators that actively switch inflammation off rather than just blocking it the way ibuprofen does Serhan 2014. It's a different lever — resolution, not suppression.

The triglyceride drop is a separate, cleaner mechanism. EPA and DHA in the liver mean less fat packaged into the particles that carry it out into your blood, more of it burned for fuel instead, and faster clearance once it's circulating. That's why the same dose that takes weeks to budge inflammation drops fasting triglycerides on a routine lab panel within a month or two Skulas-Ray 2019.

The mood-and-cognition mechanisms are less clean. EPA's antidepressant signal tracks with how much inflammation a depressed person walks in with — the pro-resolving pathway is the working hypothesis. DHA goes into the structural fats of the brain and retina, which is why pregnancy and infancy guidelines lean on it; in adults with already-formed brains, that incorporation buys less.

What we actually know

The cleanest piece of the story is triglycerides. At 4 grams a day of prescription-grade omega-3 — pure EPA or EPA plus DHA — fasting triglycerides drop 20-30% in moderate cases and over a third in severe ones, with the EPA-only formulation not raising LDL cholesterol and the mixed formulation raising it slightly AHA 2019 advisory. This is one of the most reliable biochemical effects in nutrition.

The cardiovascular endpoint — actual heart attacks, strokes, cardiac deaths — is where the field splits.

Two trials, same dose, same kind of patient, opposite answers. The unresolved question is whether REDUCE-IT's mineral-oil placebo did harm in the control arm (it nudged up LDL and inflammation markers) and exaggerated the apparent EPA benefit, or whether EPA-only really is different from EPA+DHA. The field has not settled this and no tie-breaker trial is planned.

In the broader population, the story is duller. VITAL, the largest primary-prevention trial of marine omega-3 ever run, gave 25,871 generally healthy adults 840 mg/day for over five years and found no reduction in its combined cardiovascular endpoint Manson et al. 2019. The pre-specified subgroup analysis pointed to who actually got something:

The Cochrane review pooled 86 trials and 162,796 participants and landed in the same modest territory: a small reduction in heart-disease deaths (RR 0.93) and heart-disease events (RR 0.91), with little or no effect on overall mortality or stroke Abdelhamid et al. 2020. Useful, real, narrow.

Mood

The depression literature is the second-cleanest piece. Two meta-analyses converged on the same finding: omega-3 works in major depression specifically when EPA is the dominant component — at least 60% of the EPA-plus-DHA dose — and the effect is largest as an add-on to an existing antidepressant rather than as a standalone treatment Sublette et al. 2011 Mocking et al. 2016. Effect size is moderate, not large. The version of you whose antidepressant has half-worked for months, and who picks up an EPA-rich fish-oil add-on, is the version the trials studied; for that person, this is a defensible adjunct. It is not a replacement for first-line treatment, and it sits alongside other adjuncts — exercise among them — rather than in place of them.

Cognition and dementia

Despite the elegant membrane-incorporation story, supplementing established Alzheimer's disease with DHA hasn't moved cognitive endpoints in the trials that have tested it; mixed and EPA-containing preparations do marginally better, but the signal is small and inconsistent across studies Calderon-Martinez et al. 2024. The narrower claim — that lifelong adequate intake protects the aging brain — is plausible from epidemiology but unproven in supplementation trials.

Inflammation

Meta-analyses of inflammatory blood markers (CRP, IL-6, TNF-alpha) show modest reductions at 1-3 grams a day of EPA+DHA, biggest in patients with elevated baseline inflammation. The effect exists but is not large enough that a healthy adult should expect to feel it.

What most coverage gets wrong

"Fish oil prevents heart attacks in everyone." The headline is a generalisation from observational fish-consumption data — eating two servings of oily fish a week is associated with about a third lower risk of dying from heart disease Mozaffarian & Rimm 2006 — onto the question of whether a supplement does the same thing. The supplement trials in general adults are mostly null. The benefit shows up in two conditions: low baseline fish intake, and elevated triglycerides on a statin.

"Omega-3 causes prostate cancer." A 2013 analysis of blood samples from the SELECT trial associated higher plasma omega-3 with a 43% higher rate of prostate cancer Brasky et al. 2013. It got wall-to-wall coverage. The problems: it was observational, used a single blood draw to estimate years of intake, did not measure who was supplementing, and has not been replicated in the dedicated supplement trials that have run since. VITAL found no prostate-cancer excess in 25,871 randomised participants. Treat the SELECT result as a flag worth following, not a settled finding.

"It helps dry eye." The mechanism is plausible and small open-label studies suggested benefit. The big randomised trial settled it.

"More is better, because it's just a vitamin." At 4 g/day, three independent trials (REDUCE-IT, STRENGTH, and the smaller OMEMI in elderly post-MI patients) all picked up the same signal: more new-onset atrial fibrillation in the active arm Kalstad et al. 2021 Gencer et al. 2021. Pooled, the relative increase is around 25%. That's not nothing.

"All omega-3s do the same thing." They don't. EPA dominates the cardiovascular and mood signal. DHA dominates structural incorporation into brain and retina. ALA (the plant-based precursor in flax, chia, walnuts) converts to EPA at maybe 5-10% efficiency and to DHA at under 1% — so flaxseed is not a substitute for fish or algae oil if EPA and DHA are what you want.

How to actually do this

The dose follows what you're trying to do, not a generic "fish oil number." Three brackets cover most readers.

Quality matters more than form, and it's the step most people skip — the bottle you grab off the shelf often decides whether you join the trial population that benefited or the one that got nothing. Two things go wrong. First, freshness: EPA and DHA oxidise quickly, fish oil can go rancid in the bottle, and once it does it's at best wasted and possibly mildly harmful — independent testing has repeatedly found a large share of supermarket fish oil already oxidised past voluntary freshness limits before purchase Albert et al. 2015. Second, dose: a cheap softgel can deliver two to five times less actual EPA+DHA than the "1000 mg fish oil" on the front of the label implies, because most of that gram is other fats. Read the back panel for the EPA and DHA milligrams, not the capsule size. Two practical filters:

Algae oil reaches the same blood EPA and DHA levels as fish oil at matched doses; it's the right choice for vegans and anyone who finds fish-oil burps unbearable. Form factor — triglyceride, re-esterified triglyceride, ethyl ester — matters less than purity, though ethyl-ester products need to be taken with dietary fat to be absorbed properly.

Expect blood triglycerides to drop within 4-12 weeks. The Omega-3 Index, the red-blood-cell membrane measurement that tracks long-term intake, takes about three months to reach a new steady state Harris & Von Schacky 2004. Mood effects in major depression usually take 6-12 weeks to register.

When not to take this

Pregnancy and breastfeeding are not contraindications — DHA is a structural component of fetal brain and retina development, and supplementation is broadly recommended for people with low fish intake during these life stages. The mercury-contamination concern is what limits whole-fish intake in pregnancy, not omega-3 itself.

Vegans, pregnancy, and the people who don't fit the standard pitch

The supplement aisle's default product is fish oil; two groups need a different default.

During pregnancy and breastfeeding, DHA matters for fetal brain and retinal development. The standard recommendation is 200-300 mg DHA per day, achievable through 2-3 servings/week of low-mercury fish (salmon, sardines, anchovies) or a DHA-focused supplement. Skip the high-mercury fish (king mackerel, swordfish, tilefish, bigeye tuna) for the contamination reason, not the omega-3 one.

Vegans and vegetarians cannot rely on ALA from flax, chia, or walnuts to cover EPA and DHA needs — the body converts ALA to EPA at maybe 5-10% efficiency and to DHA at under 1%. Algae oil is the right answer: it raises blood EPA and DHA at parity with fish oil and is the original biological source (fish get their omega-3 from algae either directly or up the food chain). A 1-2 g/day algae-oil supplement is the standard vegan baseline.

What ignoring this actually costs

The shape of going without depends entirely on where you're starting.

If you eat oily fish twice a week — a piece of salmon Wednesday, sardines on Friday — the rest of this article is largely not about you. The supplement trials in fish-replete adults are null; you are already in the population that the observational fish-consumption studies were looking at, and your Omega-3 Index is probably where it needs to be without doing anything else Manson et al. 2019.

If your last six months of dinners had fish in them maybe twice — most weeks none — the picture is different. The same VITAL data that found nothing in the overall population found that participants who started in your bracket had 40% fewer heart attacks over five years on the supplement Manson et al. 2019. That doesn't mean every untreated low-fish-eater has a heart attack in the next five years; it means the slope of cardiovascular risk you're walking gets gentler. Years out, that's the difference between the version of you who keeps going to your friend's daughter's wedding in your seventies and the version who's been told to stop driving after a stroke.

If your triglycerides are already high and you're on a statin, the stakes compound. The trial that tested this exact population found a real reduction in serious cardiovascular events — one event prevented for every 21 people treated Bhatt et al. 2019. Without that intervention, the version of you whose cardiologist starts every appointment by reviewing the same lab number that hasn't moved is the version that eventually gets the call about a clot.

The mood version is smaller and more conditional. If you're managing depression that's mostly worked but not fully, skipping an EPA-rich add-on means the partial response stays partial. Not catastrophic, but real, and the people around you tend to register the difference before you do.

Related entries worth looking at

  • Oily fish in the diet — the food version of this supplement, with the strongest observational evidence and the closest match to the populations the trials were trying to replicate.
  • Statins and ApoB — if cardiovascular prevention is why you're here, statins and the broader lipid-particle picture matter more than fish oil.
  • Mediterranean dietary pattern — the larger pattern that fish-eating fits inside; the omega-3 effect is hard to disentangle from it.
  • Triglyceride testing — if you've never had your fasting triglycerides measured, the prescription-fish-oil question can't be asked yet.
  • Treatment-resistant depression — where the EPA adjunct story lives, alongside other augmentation strategies.
დაკავშირებული სახელმძღვანელოში
აუარესებს / ამძიმებს
  • — At high doses the same fish oil that lowers triglycerides raises atrial-fibrillation risk — more is not better.
ეხმარება
  • — One of omega-3's narrower real uses is dry eye from meibomian gland dysfunction.
  • — EPA-heavy fish oil is a defensible add-on when depression is stuck on a drug — alongside, not instead of, exercise.
ალტერნატივები
  • — For low-grade inflammation and sore joints, omega-3 and turmeric pull the same lever; omega-3 is the safer pick if you take prescription drugs.
დაკავშირებული
  • — If this panel shows high triglycerides, prescription omega-3 is one of the most reliable ways to bring them down.
  • — For high triglycerides on a statin, EPA-heavy omega-3 is one of the add-on tools in the lipid-lowering toolkit.
  • — The omega-3 debate is partly about balancing the omega-6-heavy seed oils most people already eat a lot of.
  • — Omega-3 and NAD precursors often share a shelf, but omega-3 has settled indications while NAD's clinical payoff is unproven.
·
536